Cargando…

Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults

OBJECTIVE: HBV vaccine induces protective antibodies only in 23–56% of HIV-infected children. The aim of our study is to evaluate the immunologic effects of a booster dose of HBV vaccine in HIV-infected youth. DESIGN: 53 young HIV-infected patients in whom HBV vaccination did not elicit protective A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giacomet, Vania, Masetti, Michela, Nannini, Pilar, Forlanini, Federica, Clerici, Mario, Zuccotti, Gian Vincenzo, Trabattoni, Daria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812642/ https://www.ncbi.nlm.nih.gov/pubmed/29444185 http://dx.doi.org/10.1371/journal.pone.0192638

Ejemplares similares

Early-Transmitted Variants and Their Evolution in a HIV-1 Positive Couple: NGS and Phylogenetic Analyses
por: Lai, Alessia, et al.
Publicado: (2021)

Immunological Characterization of HIV and SARS-CoV-2 Coinfected Young Individuals
por: Vanetti, Claudia, et al.
Publicado: (2021)

Switching to Integrase Inhibitors Unlinked to Weight Increase in Perinatally HIV-Infected Young Adults and Adolescents: A 10-Year Observational Study
por: Taramasso, Lucia, et al.
Publicado: (2020)

HPV vaccination in HIV+ adolescents and young adults induces strong HPV-specific immune responses
por: Rainone, V, et al.
Publicado: (2014)

Gut and mesenteric lymph node involvement in pediatric patients infected with human immunodeficiency virus
por: Mantegazza, Cecilia, et al.
Publicado: (2014)

Maraviroc Reduces Arterial Stiffness in PI-Treated HIV-infected Patients
por: Piconi, Stefania, et al.
Publicado: (2016)

Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication
por: Trabattoni, Daria, et al.
Publicado: (2016)

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population
por: Rusconi, Stefano, et al.
Publicado: (2012)

The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age
por: Vanetti, Claudia, et al.
Publicado: (2023)

Antiretroviral compounds affect the granule-dependent mechanisms of lysis in CD8 T cells
por: Parmigiani, Anita, et al.
Publicado: (2006)

The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery
por: Bandera, Alessandra, et al.
Publicado: (2018)

Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
por: Saresella, Marina, et al.
Publicado: (2022)

Congenital CMV, Lights and Shadows on Its Management: The Experience of a Reference Center in Northern Italy
por: Rubinacci, Valeria, et al.
Publicado: (2022)

Acute myocardial injury: a novel clinical pattern in children with COVID-19
por: Wolfler, Andrea, et al.
Publicado: (2020)

Is There Any Opportunity to Provide an HBV Vaccine Booster Dose before Anti-Hbs Titer Vanishes?
por: Papadopoli, Rosa, et al.
Publicado: (2020)

Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein
por: Varotto-Boccazzi, Ilaria, et al.
Publicado: (2022)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
por: Wroński, Jakub, et al.
Publicado: (2022)

Saliva sampling for chasing SARS-CoV-2: A Game-changing strategy
por: Borghi, Elisa, et al.
Publicado: (2021)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Prospective Immune Dynamics during the First 24 Weeks of Efavirenz Based-Antiretroviral Therapy in HIV-1-Infected Subjects, According to CD4(+) T-Cell Counts at Presentation: The IMMUNEF Clinical Trial
por: Soria, Alessandro, et al.
Publicado: (2015)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
por: Wroński, Jakub, et al.
Publicado: (2023)

Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan?
por: Barcellini, Lucia, et al.
Publicado: (2021)

HBV Seroprotection and Anamnestic Response to Booster Vaccination in Pediatric Cancer Survivors
por: Suwanpakdee, Detchvijitr, et al.
Publicado: (2021)

Effectiveness of Booster Dose of Anti SARS-CoV-2 BNT162b2 in Cirrhosis: Longitudinal Evaluation of Humoral and Cellular Response
por: Giambra, Vincenzo, et al.
Publicado: (2022)

Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
por: Storti, Paola, et al.
Publicado: (2022)

Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV
por: Vanwolleghem, Thomas, et al.
Publicado: (2021)

Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants
por: Berzi, Angela, et al.
Publicado: (2016)

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human
por: Zhang, Yuwei, et al.
Publicado: (2022)

Serum C reactive protein predicts humoral response after BNT162b2 booster administration
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence
por: van der Sande, Marianne A.B., et al.
Publicado: (2007)

Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study
por: Yang, Lu M., et al.
Publicado: (2022)

Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2022)

Preschool-located influenza vaccination and influenza-like illness surveillance: an Italian pilot experience
por: Amendola, Antonella, et al.
Publicado: (2023)

Qualitative Immune Modulation by Interleukin-2 (IL-2) Adjuvant Therapy in Immunological Non Responder HIV-Infected Patients
por: Sabbatini, Francesca, et al.
Publicado: (2010)

Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
por: Rainone, Veronica, et al.
Publicado: (2016)

Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
por: Ruggieri, Serena, et al.
Publicado: (2023)

Fully Immunocompetent CD8+ T Lymphocytes Are Present in Autologous Haematopoietic Stem Cell Transplantation Recipients Despite an Ineffectual T-Helper Response
por: Bandera, Alessandra, et al.
Publicado: (2008)

Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice
por: Catalioto, Rose-Marie, et al.
Publicado: (2021)

Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatments
por: Piubelli, Chiara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_atpn5jigc9c4ksn157sud3clus